Journal
CLINICS IN CHEST MEDICINE
Volume 33, Issue 3, Pages 559-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2012.06.006
Keywords
Inflammation; Resolution; Lipoxins; Mediators; Asthma
Categories
Funding
- National Institutes of Health
- Med Bio Med
- US National Institutes of Health grants [AI0680 34, P01-GM095467, U10-HL109172, P50-HL107166]
Ask authors/readers for more resources
The resolution of inflammation in healthy airways is an active process, with specialized mediators and cellular mechanisms enlisted to restore tissue homeostasis. This article focuses on recent discoveries of natural mediators derived from essential fatty acids, including omega-3 fatty acids, with anti-inflammatory and pro-resolving. These pro-resolving mediators serve as agonists at specific receptors. Asthma is an incurable disease of chronic, nonresolving inflammation of the airways. While the biosynthesis of pro-resolving mediators occurs during asthma, defects in their production are associated with disease severity, suggesting that the pathobiology of asthma may result in part from impaired resolution of airway inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available